Zhiqiang Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Zhiqiang Chen has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Tingting Feng
Jiangsu Key Laboratory of Infection and Immunity, Institute of Biology and Medical Sciences, Soochow University, Suzhou, China
5 shared publications - Jianfeng Dai
Jiangsu Key Laboratory of Infection and Immunity, Institute of Biology and Medical Sciences, Soochow University, Suzhou, China
3 shared publications Jiahui Wu
Institute of Biology & Medical Sciences, Jiangsu Key Laboratory of Infection & Immunity, Soochow University, Suzhou, 215123, Jiangsu Province, China
2 shared publicationsJinyu Zhang
Institute of Biology and Medical Sciences, MOE Key Laboratory of Geriatric Diseases and Immunology, Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, China
2 shared publicationsQiaoqiao Chen
Institute of Biology & Medical Sciences, Jiangsu Key Laboratory of Infection & Immunity, Soochow University, Suzhou, 215123, Jiangsu Province, China
2 shared publicationsXue Han
Department of Clinical Laboratory, the Affiliated Hospital of Qingdao University, 59 Haier Road, Qingdao, 266000, Shandong Province, China
2 shared publications
Latest Publications
- Open Access
- 20 September 2024
- Published by Wolters Kluwer Health in Hepatology
- Vol. 82 (1) , 110-126
Harnessing ZIKV NS2A RNA for alleviating acute hepatitis and cytokine release storm by targeting translation machinery
Background and Aims: Hyperactivated inflammatory responses induced by cytokine release syndrome are the primary causes of tissue damage and even death. The translation process is precisely regulated to control the production of proinflammatory cytokines. However, it is largely unknown whether targeting translation can effectively limit the hyperactivated inflammatory responses during acute hepatitis and graft-versus-host disease. Approach and Results: By using in vitro translation and cellular overexpression systems, we have found that the nonstructural protein gene NS2A of Zika virus functions as RNA molecules to suppress the translation of both ectopic genes and endogenous proinflammatory cytokines. Mechanistically, results from RNA pulldown and co-immunoprecipitation assays have demonstrated that NS2A RNA interacts with the translation initiation factor eIF2α to disrupt the dynamic balance of the eIF2/eIF2B complex and translation initiation, which is the rate-limiting step of translation. In the acetaminophen-induced, lipopolysaccharide/D-galactosamine-induced, viral infection-induced acute hepatitis, and graft-versus-host disease mouse models, mice with myeloid cell-specific knock-in of NS2A show decreased levels of serum proinflammatory cytokines and reduced tissue damage. Conclusions: Zika virus NS2A dampens the production of proinflammatory cytokines and alleviates inflammatory injuries by interfering translation process as RNA molecules, which suggests that NS2A RNA is potentially used to treat numerous acute inflammatory diseases characterized by cytokine release syndrome.
- 20 September 2024
- Published by Wolters Kluwer Health in Hepatology
- Vol. 82 (1) , 110-126
Open AccessHarnessing ZIKV NS2A RNA for alleviating acute hepatitis and cytokine release storm by targeting translation machinery
Background and Aims: Hyperactivated inflammatory responses induced by cytokine release syndrome are the primary causes of tissue damage and even death. The translation process is precisely regulated to control the production of proinflammatory cytokines. However, it is largely unknown whether targeting translation can effectively limit the hyperactivated inflammatory responses during acute hepatitis and graft-versus-host disease. Approach and Results: By using in vitro translation and cellular overexpression systems, we have found that the nonstructural protein gene NS2A of Zika virus functions as RNA molecules to suppress the translation of both ectopic genes and endogenous proinflammatory cytokines. Mechanistically, results from RNA pulldown and co-immunoprecipitation assays have demonstrated that NS2A RNA interacts with the translation initiation factor eIF2α to disrupt the dynamic balance of the eIF2/eIF2B complex and translation initiation, which is the rate-limiting step of translation. In the acetaminophen-induced, lipopolysaccharide/D-galactosamine-induced, viral infection-induced acute hepatitis, and graft-versus-host disease mouse models, mice with myeloid cell-specific knock-in of NS2A show decreased levels of serum proinflammatory cytokines and reduced tissue damage. Conclusions: Zika virus NS2A dampens the production of proinflammatory cytokines and alleviates inflammatory injuries by interfering translation process as RNA molecules, which suggests that NS2A RNA is potentially used to treat numerous acute inflammatory diseases characterized by cytokine release syndrome.
- 28 March 2024
- Published by Elsevier in Antiviral Research
- Vol. 225, 105875
DDX20 positively regulates the interferon pathway to inhibit viral infection
- 28 March 2024
- Published by Elsevier in Antiviral Research
- Vol. 225, 105875
DDX20 positively regulates the interferon pathway to inhibit viral infection
- Open Access
- 18 May 2023
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 385 (S3) , 240
Sanggenon G, a Diels-Alder Adduct Screened from Mori Cortex, Attenuated Irinotecan-induced Late-onset Diarrhea in Mice via a Dual Inhibition Mechanism
ID 22783 Poster Board 240 Irinotecan (IRT) is the first-line treatment of advanced colorectal cancer (CRC). But its dose intensification was limited by severe diarrhea resulted from regeneration of the toxic metabolite SN-38 by gut microbial β-glucuronidase enzymes (GUSs)1,2. The extreme structural and functional complexity of GUSs has posed big challenges to identifying GUSs involved in SN-38G deconjugation3. As a compromise, we employed a specific reaction guided broad-spectrum GUS inhibition strategy to discover inhibitors for alleviating IRT-induced late diarrhea. Specifically, inhibitors were screened in vitro using a 3-in-1 screening system consisting of human gut microbiota pool, representative GUS-expressing bacterial isolates and GUS proteins selected based on their metabolic profiles towards a urinary endogenous compounds pool and/or reported roles in CRC. Natural compounds of different chemical types were screened, among which flavonoid compounds, in particular the Diels-Alder (DA) adducts uniquely distributed in the plants of Morus genus, showed strong GUS inhibition activity towards the pool. Using activity-guided isolation with the pool combining virtual screening with EcoGUS from Escherichia coli, SpasGUS from Staphylococcus pasteuri and SagaGUS from Streptococcus agalactiae, we finally predicted GUS inhibition potentials of >40 DA compounds based on the S and RMSD values using MOE software and identified key structural factors for the protein-inhibitor interactions. Six DA compounds were isolated from Mori Cortex, all showing strong inhibition towards the GUS activity of the pool (73-94% at 100μM), the isolates and the proteins. Sangennon G (SGG) which showed IC50 of 0.16-0.64 μM towards purified GUSs was further assessed in mice. SGG (0.5 mg/kg, p.o. twice daily) protected mice from severe diarrhea, high mortality and intestinal injury induced by IRT (50 mg/kg/day, i.p.), agreeing well with decreased GUS activity, increased intestinal SN-38 glucuronidation and diminished colonic SN-38 accumulation. It’s interesting to note that SGG also effectively suppressed OATP2B1-mediated SN-38 uptake by Caco-2 cells (IC50 4 μM). Amoxapine (2.50 mg/kg, p.o. twice daily), a potent EcoGUS inhibitor, was less effective in rescuing irinotecan-induced toxicity due to weaker GUS inhibition (the pool IC50 >100 μM) and nil effect on SN-38 intestinal uptake. In conclusion, our specific reaction guided broad-spectrum GUS inhibition strategy and the 3-in-1 system were demonstrated to be feasible to cope with the extreme complexity of gut microbial GUSs. The dual inhibition mechanism makes SGG superior to other known GUS inhibitors in alleviating IRT toxicity. [Supported by the Science and Technology Development fund of Macao SAR (0091/2021/A2, 0098/2019/A2), Shenzhen-Hong Kong-Macau Science and Technology Program Category C (SGDX20210823103805038), Guangdong Natural Science Fund (2019A1515012195), and University of Macau (MYRG2018-00091-ICMS-QRCM)]. References: 1. Fujita, D, et al (2016) Drug Metab. Dispos 44: 1-7. 2. Maroun JA, et. al (2007) Curr. Oncol 14: 13–20. 3. Wang PP, et. al (2021) Biochem Pharmacol 190: 114566 [Supported by the Science and Technology Development fund of Macao SAR (0091/2021/A2, 0098/2019/A2), Shenzhen-Hong Kong-Macau Science and Technology Program Category C (SGDX20210823103805038), Guangdong Natural Science Fund (2019A1515012195), and University of Macau (MYRG2018-00091-ICMS-QRCM)]. N/A
- 18 May 2023
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 385 (S3) , 240
Open AccessSanggenon G, a Diels-Alder Adduct Screened from Mori Cortex, Attenuated Irinotecan-induced Late-onset Diarrhea in Mice via a Dual Inhibition Mechanism
ID 22783 Poster Board 240 Irinotecan (IRT) is the first-line treatment of advanced colorectal cancer (CRC). But its dose intensification was limited by severe diarrhea resulted from regeneration of the toxic metabolite SN-38 by gut microbial β-glucuronidase enzymes (GUSs)1,2. The extreme structural and functional complexity of GUSs has posed big challenges to identifying GUSs involved in SN-38G deconjugation3. As a compromise, we employed a specific reaction guided broad-spectrum GUS inhibition strategy to discover inhibitors for alleviating IRT-induced late diarrhea. Specifically, inhibitors were screened in vitro using a 3-in-1 screening system consisting of human gut microbiota pool, representative GUS-expressing bacterial isolates and GUS proteins selected based on their metabolic profiles towards a urinary endogenous compounds pool and/or reported roles in CRC. Natural compounds of different chemical types were screened, among which flavonoid compounds, in particular the Diels-Alder (DA) adducts uniquely distributed in the plants of Morus genus, showed strong GUS inhibition activity towards the pool. Using activity-guided isolation with the pool combining virtual screening with EcoGUS from Escherichia coli, SpasGUS from Staphylococcus pasteuri and SagaGUS from Streptococcus agalactiae, we finally predicted GUS inhibition potentials of >40 DA compounds based on the S and RMSD values using MOE software and identified key structural factors for the protein-inhibitor interactions. Six DA compounds were isolated from Mori Cortex, all showing strong inhibition towards the GUS activity of the pool (73-94% at 100μM), the isolates and the proteins. Sangennon G (SGG) which showed IC50 of 0.16-0.64 μM towards purified GUSs was further assessed in mice. SGG (0.5 mg/kg, p.o. twice daily) protected mice from severe diarrhea, high mortality and intestinal injury induced by IRT (50 mg/kg/day, i.p.), agreeing well with decreased GUS activity, increased intestinal SN-38 glucuronidation and diminished colonic SN-38 accumulation. It’s interesting to note that SGG also effectively suppressed OATP2B1-mediated SN-38 uptake by Caco-2 cells (IC50 4 μM). Amoxapine (2.50 mg/kg, p.o. twice daily), a potent EcoGUS inhibitor, was less effective in rescuing irinotecan-induced toxicity due to weaker GUS inhibition (the pool IC50 >100 μM) and nil effect on SN-38 intestinal uptake. In conclusion, our specific reaction guided broad-spectrum GUS inhibition strategy and the 3-in-1 system were demonstrated to be feasible to cope with the extreme complexity of gut microbial GUSs. The dual inhibition mechanism makes SGG superior to other known GUS inhibitors in alleviating IRT toxicity. [Supported by the Science and Technology Development fund of Macao SAR (0091/2021/A2, 0098/2019/A2), Shenzhen-Hong Kong-Macau Science and Technology Program Category C (SGDX20210823103805038), Guangdong Natural Science Fund (2019A1515012195), and University of Macau (MYRG2018-00091-ICMS-QRCM)]. References: 1. Fujita, D, et al (2016) Drug Metab. Dispos 44: 1-7. 2. Maroun JA, et. al (2007) Curr. Oncol 14: 13–20. 3. Wang PP, et. al (2021) Biochem Pharmacol 190: 114566 [Supported by the Science and Technology Development fund of Macao SAR (0091/2021/A2, 0098/2019/A2), Shenzhen-Hong Kong-Macau Science and Technology Program Category C (SGDX20210823103805038), Guangdong Natural Science Fund (2019A1515012195), and University of Macau (MYRG2018-00091-ICMS-QRCM)]. N/A
- Open Access
- 7 March 2023
- Published by Frontiers Media SA in Frontiers in Environmental Science
- Vol. 11
Research on environmental regulation, environmental protection tax, and earnings management
After the Chinese government put forward carbon peaking and carbon neutrality goals, the intensity of environmental regulation has reached an unprecedented height. Using a sample of heavily polluted A-share listed companies in Shanghai and Shenzhen from 2012 to 2018, we discuss the influence mechanism of environmental regulation and environmental tax on corporate earnings management in this study. We use multiple regression models to empirically verify the impact of environmental regulation, environmental tax, and their combined effect on corporate earnings management. We find that environmental regulations promote enterprises’ upward real earnings management and inhibit enterprises’ upward accrual earnings management. However, environmental taxes discourage firms from upward accrual earnings management. Moreover, environmental regulations and environmental tax jointly promote enterprises’ upward accrual earnings management and real earnings management. And there is heterogeneity among different enterprise natures, different enterprise sizes, enterprises in regions with different degrees of marketization, different intensities of government investment in environmental protection, and whether enterprises disclose their environmental protection concepts. The contribution of this paper is to put environmental regulation, environmental protection tax, and earnings management in the same analytical framework. We aim to combine the government’s macro policy with the enterprise’s micro behavior and to deeply analyze the impact and mechanism of environmental regulation, environmental protection tax, and their combined effect on enterprise earnings management. By analyzing the heterogeneity of these impacts from multiple dimensions, this study tries to expand the research horizon, fill the research gap, and provide theoretical support for the government to formulate comprehensive environmental regulation policies.
- 7 March 2023
- Published by Frontiers Media SA in Frontiers in Environmental Science
- Vol. 11
Open AccessResearch on environmental regulation, environmental protection tax, and earnings management
After the Chinese government put forward carbon peaking and carbon neutrality goals, the intensity of environmental regulation has reached an unprecedented height. Using a sample of heavily polluted A-share listed companies in Shanghai and Shenzhen from 2012 to 2018, we discuss the influence mechanism of environmental regulation and environmental tax on corporate earnings management in this study. We use multiple regression models to empirically verify the impact of environmental regulation, environmental tax, and their combined effect on corporate earnings management. We find that environmental regulations promote enterprises’ upward real earnings management and inhibit enterprises’ upward accrual earnings management. However, environmental taxes discourage firms from upward accrual earnings management. Moreover, environmental regulations and environmental tax jointly promote enterprises’ upward accrual earnings management and real earnings management. And there is heterogeneity among different enterprise natures, different enterprise sizes, enterprises in regions with different degrees of marketization, different intensities of government investment in environmental protection, and whether enterprises disclose their environmental protection concepts. The contribution of this paper is to put environmental regulation, environmental protection tax, and earnings management in the same analytical framework. We aim to combine the government’s macro policy with the enterprise’s micro behavior and to deeply analyze the impact and mechanism of environmental regulation, environmental protection tax, and their combined effect on enterprise earnings management. By analyzing the heterogeneity of these impacts from multiple dimensions, this study tries to expand the research horizon, fill the research gap, and provide theoretical support for the government to formulate comprehensive environmental regulation policies.
- 1 January 2023
- Published by Taylor & Francis in Future Virology
- Vol. 18 (1) , 51-62
SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening
The ongoing COVID-19 pandemic caused by the SARS-CoV-2 has necessitated rapid development of drug screening tools. RNA-dependent RNA polymerase (RdRp) is a promising target due to its essential functions in replication and transcription of viral genome. To date, through minimal RNA synthesizing machinery established from cryo-electron microscopy structural data, there has been development of high-throughput screening assays for directly screening inhibitors that target the SARS-CoV-2 RdRp. Here, we analyze and present verified techniques that could be used to discover potential anti-RdRp agents or repurposing of approved drugs to target the SARS-CoV-2 RdRp. In addition, we highlight the characteristics and application value of cell-free or cell-based assays in drug discovery.
- 1 January 2023
- Published by Taylor & Francis in Future Virology
- Vol. 18 (1) , 51-62
SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening
The ongoing COVID-19 pandemic caused by the SARS-CoV-2 has necessitated rapid development of drug screening tools. RNA-dependent RNA polymerase (RdRp) is a promising target due to its essential functions in replication and transcription of viral genome. To date, through minimal RNA synthesizing machinery established from cryo-electron microscopy structural data, there has been development of high-throughput screening assays for directly screening inhibitors that target the SARS-CoV-2 RdRp. Here, we analyze and present verified techniques that could be used to discover potential anti-RdRp agents or repurposing of approved drugs to target the SARS-CoV-2 RdRp. In addition, we highlight the characteristics and application value of cell-free or cell-based assays in drug discovery.
- Open Access
- 12 December 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 158, 114127
From degenerative disease to malignant tumors: Insight to the function of ApoE
- 12 December 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 158, 114127
Open AccessFrom degenerative disease to malignant tumors: Insight to the function of ApoE
- Open Access
- 25 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11308
Protein Acetylation Going Viral: Implications in Antiviral Immunity and Viral Infection
During viral infection, both host and viral proteins undergo post-translational modifications (PTMs), including phosphorylation, ubiquitination, methylation, and acetylation, which play critical roles in viral replication, pathogenesis, and host antiviral responses. Protein acetylation is one of the most important PTMs and is catalyzed by a series of acetyltransferases that divert acetyl groups from acetylated molecules to specific amino acid residues of substrates, affecting chromatin structure, transcription, and signal transduction, thereby participating in the cell cycle as well as in metabolic and other cellular processes. Acetylation of host and viral proteins has emerging roles in the processes of virus adsorption, invasion, synthesis, assembly, and release as well as in host antiviral responses. Methods to study protein acetylation have been gradually optimized in recent decades, providing new opportunities to investigate acetylation during viral infection. This review summarizes the classification of protein acetylation and the standard methods used to map this modification, with an emphasis on viral and host protein acetylation during viral infection.
- 25 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11308
Open AccessProtein Acetylation Going Viral: Implications in Antiviral Immunity and Viral Infection
During viral infection, both host and viral proteins undergo post-translational modifications (PTMs), including phosphorylation, ubiquitination, methylation, and acetylation, which play critical roles in viral replication, pathogenesis, and host antiviral responses. Protein acetylation is one of the most important PTMs and is catalyzed by a series of acetyltransferases that divert acetyl groups from acetylated molecules to specific amino acid residues of substrates, affecting chromatin structure, transcription, and signal transduction, thereby participating in the cell cycle as well as in metabolic and other cellular processes. Acetylation of host and viral proteins has emerging roles in the processes of virus adsorption, invasion, synthesis, assembly, and release as well as in host antiviral responses. Methods to study protein acetylation have been gradually optimized in recent decades, providing new opportunities to investigate acetylation during viral infection. This review summarizes the classification of protein acetylation and the standard methods used to map this modification, with an emphasis on viral and host protein acetylation during viral infection.
- 31 January 2022
- Published by Wiley in Journal of Fish Diseases
- Vol. 45 (5) , 743-754
As‐Cathelicidin4 enhances the immune response and resistance against Aeromonas hydrophila in caridean shrimp
- 31 January 2022
- Published by Wiley in Journal of Fish Diseases
- Vol. 45 (5) , 743-754
As‐Cathelicidin4 enhances the immune response and resistance against Aeromonas hydrophila in caridean shrimp
- 12 July 2016
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 473 (14) , 2131-2139
miR-30a can inhibit DNA replication by targeting RPA1 thus slowing cancer cell proliferation
Cell proliferation was inhibited following forced over-expression of miR-30a in the ovary cancer cell line A2780DX5 and the gastric cancer cell line SGC7901R. Interestingly, miR-30a targets the DNA replication protein RPA1, hinders the replication of DNA and induces DNA fragmentation. Furthermore, ataxia telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2) were phosphorylated after DNA damage, which induced p53 expression, thus triggering the S-phase checkpoint, arresting cell cycle progression and ultimately initiating cancer cell apoptosis. Therefore, forced miR-30a over-expression in cancer cells can be a potential way to inhibit tumour development.
- 12 July 2016
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 473 (14) , 2131-2139
miR-30a can inhibit DNA replication by targeting RPA1 thus slowing cancer cell proliferation
Cell proliferation was inhibited following forced over-expression of miR-30a in the ovary cancer cell line A2780DX5 and the gastric cancer cell line SGC7901R. Interestingly, miR-30a targets the DNA replication protein RPA1, hinders the replication of DNA and induces DNA fragmentation. Furthermore, ataxia telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2) were phosphorylated after DNA damage, which induced p53 expression, thus triggering the S-phase checkpoint, arresting cell cycle progression and ultimately initiating cancer cell apoptosis. Therefore, forced miR-30a over-expression in cancer cells can be a potential way to inhibit tumour development.
- Open Access
- 1 April 2014
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 9, 2043-50
Apoptosis selectively induced in BEL-7402 cells by folic acid-modified magnetic nanoparticles combined with 100 Hz magnetic field
Objective: To explore the effect of folic acid-modified magnetic nanoparticles (FA-MNPs) combined with a 100 Hz extremely low-frequency electromagnetic field (ELF-EMF) on the apoptosis of liver cancer BEL-7402 cells. Materials and methods: MNPs (20 nm) were prepared by coprecipitation, and then folic acid was coated onto MNPs to prepare FA-MNPs. BEL-7402 cells and HL7702 cells were selected as liver cancer cells and normal liver cells, respectively. The ELF-EMF was generated from a solenoid coil. Cellular uptake of NPs was determined by inductively coupled plasma atomic emission spectroscopy. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to evaluate cell inhibition. Apoptosis was analyzed by flow cytometry. Statistical analyses were performed using two-way analysis of variance. Results: FA-MNPs combined with a 100 Hz magnetic field significantly inhibited cell proliferation and induced higher apoptosis compared to either the ELF-EMF alone or FA-MNPs alone. FA-MNPs showed a better apoptosis effect and higher iron uptake in BEL-7402 cells compared to in HL7702 cells. On the basis of the ELF-EMF, higher doses of FA-MNPs brought higher apoptosis and higher iron uptake in either BEL-7402 cells or HL7702 cells. Conclusion: These results suggest that FA-MNPs may induce apoptosis in a cellular iron uptake-dependent manner when combined with an ELF-EMF in BEL-7402 cells.
- 1 April 2014
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 9, 2043-50
Open AccessApoptosis selectively induced in BEL-7402 cells by folic acid-modified magnetic nanoparticles combined with 100 Hz magnetic field
Objective: To explore the effect of folic acid-modified magnetic nanoparticles (FA-MNPs) combined with a 100 Hz extremely low-frequency electromagnetic field (ELF-EMF) on the apoptosis of liver cancer BEL-7402 cells. Materials and methods: MNPs (20 nm) were prepared by coprecipitation, and then folic acid was coated onto MNPs to prepare FA-MNPs. BEL-7402 cells and HL7702 cells were selected as liver cancer cells and normal liver cells, respectively. The ELF-EMF was generated from a solenoid coil. Cellular uptake of NPs was determined by inductively coupled plasma atomic emission spectroscopy. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to evaluate cell inhibition. Apoptosis was analyzed by flow cytometry. Statistical analyses were performed using two-way analysis of variance. Results: FA-MNPs combined with a 100 Hz magnetic field significantly inhibited cell proliferation and induced higher apoptosis compared to either the ELF-EMF alone or FA-MNPs alone. FA-MNPs showed a better apoptosis effect and higher iron uptake in BEL-7402 cells compared to in HL7702 cells. On the basis of the ELF-EMF, higher doses of FA-MNPs brought higher apoptosis and higher iron uptake in either BEL-7402 cells or HL7702 cells. Conclusion: These results suggest that FA-MNPs may induce apoptosis in a cellular iron uptake-dependent manner when combined with an ELF-EMF in BEL-7402 cells.